Healthcare Services

Gastric Ulcers Market Analysis Reflecting Expansion Trends And Industry Performance

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, How Much Growth In Market Size Is Expected For The Gastric Ulcers Market?

The market size for gastric ulcers has shown significant growth in recent years. This market is set to expand from $4.53 billion in 2025 to $4.78 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.5%. In the past, this expansion can be ascribed to several factors, including the widespread prevalence of h pylori infection, the extensive use of antacids, the availability of antibiotics, the provision of hospital-based GI treatments, and the increasing adoption of endoscopic diagnosis.

The gastric ulcers market size is anticipated to experience consistent expansion over the coming years. This market is projected to reach $5.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.9%. Factors contributing to this growth during the forecast period include the evolution of advanced acid-suppression medications, the escalating need for prolonged ulcer care, an increase in outpatient services, advancements in diagnostic techniques, and a rise in lifestyle-associated conditions. Key trends expected within this period encompass a greater adoption of proton pump inhibitors, an intensifying emphasis on helicobacter pylori eradication, an expansion in combination drug treatments, the broadening of non-invasive diagnostic approaches, and heightened public understanding of gastrointestinal conditions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp

Which Core Factors Are Supporting The Expansion Of The Gastric Ulcers Market?

The expanding demographic of older adults is projected to stimulate the growth of the gastric ulcers market in the coming years. This elderly demographic generally consists of individuals aged 65 and above, who often have unique health concerns associated with the aging process. The rise in the geriatric population stems from progress in healthcare, which contributes to extended life expectancies and reduced birth rates across numerous global regions. Gastric ulcers frequently occur among the elderly, largely attributed to higher consumption of NSAIDs and diminished mucosal protection, which often elevates the danger of complications. For example, in January 2024, the Population Reference Bureau (PRB), a US-based private non-profit organization, reported that the population of Americans aged 65 and older is anticipated to climb from 58 million in 2022 to 82 million by 2050, indicating a 47% increase. Furthermore, this demographic’s share of the total population is expected to increase from 17% to 23%. This evolution signifies a notable aging pattern within the U.S. population. These forecasts underscore the growing necessity to address the requirements of older individuals across various sectors. Consequently, the expanding geriatric population is propelling the growth of the gastric ulcers market.

What Segment Types Are Included In The Gastric Ulcers Market Analysis?

The gastric ulcers market covered in this report is segmented –

1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes

2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole

2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine

3) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate

4) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline

5) By Cytoprotective Agents: Sucralfate, Misoprostol, Bismuth Subsalicylate

6) By Other Drug Classes: Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies

Which Trends Are Shaping The Gastric Ulcers Market Landscape?

Leading entities operating within the gastric ulcer market are emphasizing the creation of innovative products, including novel drug formulations, to enhance treatment effectiveness and mitigate side effects. New formulation drugs pertain to medicines crafted with advanced combinations of active ingredients, delivery systems, or dosage forms to improve their efficacy, safety, and patient adherence. For example, in June 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical preparation manufacturing company, unveiled Rabeprazole + Levosulpiride SR Capsules to deliver improved relief for conditions such as gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. These offerings incorporate a proton pump inhibitor and a prokinetic agent, successfully managing gastrointestinal ailments like gastroesophageal reflux disease (GERD) and gastric ulcers. This specific formulation not only reduces gastric acid secretion but also enhances gastric motility, thereby providing comprehensive relief from symptoms such as heartburn and indigestion.

Who Are The Companies Shaping The Gastric Ulcers Market Landscape?

Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC

Access The Complete Gastric Ulcers Market Report:

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Which Region Stands As The Largest Contributor To The Gastric Ulcers Market?

North America was the largest region in the gastric ulcers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Gastric Ulcers Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=17160&type=smp

Browse Through More Reports Similar to the Global Gastric Ulcers Market 2026, By The Business Research Company

Gastric Cancer Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Gastric Ulcers Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Esophageal Cancer Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795